Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A severe combined immunodeficiency that is the result of a mutation on Chromosome 6 RAG2 gene involving genetic rearrangement of both the T- and B-lymphocyte receptor genes.
No clinical trials have been registered for recombinase activating gene 2 deficiency.
29 publications have been identified in PubMed for recombinase activating gene 2 deficiency. Research spans Basic Science / Preclinical (72%), Gene Therapy / Novel Therapeutics (14%), and Review / Meta-Analysis (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 21 | 72% |
New treatment approaches | 4 |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 11:31 PM UTC
14%
Research summaries | 2 | 7% |
Clinical study results | 1 | 3% |
Disease patterns and progression | 1 | 3% |
Huang K (2026). [PMID: 42021739](https://pubmed.ncbi.nlm.nih.gov/42021739/). *Circ Res*. [Basic Science / Preclinical]
Dennaoui R (2026). [PMID: 41405992](https://pubmed.ncbi.nlm.nih.gov/41405992/). *Cell reports*. [Basic Science / Preclinical]
Dimitrova D (2026). [PMID: 41765109](https://pubmed.ncbi.nlm.nih.gov/41765109/). *The Journal of allergy and clinical immunology*. [Basic Science / Preclinical]
Duan S (2026). [PMID: 41723447](https://pubmed.ncbi.nlm.nih.gov/41723447/). *Molecular cancer*. [Basic Science / Preclinical]
Lyu C (2026). [PMID: 41115526](https://pubmed.ncbi.nlm.nih.gov/41115526/). *Cellular and molecular gastroenterology and hepatology*. [Basic Science / Preclinical]
Huang F (2026). [PMID: 41885504](https://pubmed.ncbi.nlm.nih.gov/41885504/). *The FEBS journal*. [Basic Science / Preclinical]
Han XY (2026). [PMID: 42189612](https://pubmed.ncbi.nlm.nih.gov/42189612/). *J Am Soc Nephrol*. [Basic Science / Preclinical]
Ver Heul AM (2025). [PMID: 40326866](https://pubmed.ncbi.nlm.nih.gov/40326866/). *eLife*. [Basic Science / Preclinical]
Li H (2025). [PMID: 39892701](https://pubmed.ncbi.nlm.nih.gov/39892701/). *Cancer letters*. [Basic Science / Preclinical]
Amarsanaa E (2025). [PMID: 40308947](https://pubmed.ncbi.nlm.nih.gov/40308947/). *NAR cancer*. [Basic Science / Preclinical]